MDMA or Ectasy
General Concepts
- ALL addictive drugs act on the dopamine mesolimbic-reward pathway
- Withdrawal symptoms are often the opposite of intoxication
- e.g.) miosis in opioid intoxication and mydriasis in withdrawal
- Depressant withdrawal is generally more life-threatening than stimulant withdrawal
- Injection drug users at risk for
- right-sided endocarditis
- hepatitis and abscesses
- overdose
- hemorrhoids
- HIV/AIDS
Depressants
- Opioids (e.g. morphine, heroin, and methadone)
- intoxication
- nausea and vomiting with constipation
- respiratory depression
- pupillary constriction (pinpoint pupils = miosis)
- seizures (overdose is life-threatening)
- for heroin use look for track marks (needle injections)
- treatment for intoxication
- naloxone/naltrexone
- opioid receptor antagonist
- symptomatic treatment
- withdrawal
- anxiety, insomnia, anorexia, sweating, dilated pupils, piloerection ("cold turkey"), fever, rhinorrhea, nausea, stomach cramps, diarrhea ("flulike" symptoms), muscle jerks, and yawning
- unpleasant but not life-threatening
- treatment for withdrawal (examples mainly for heroin)
- methadone
- long-acting IV opiate
- used for heroin detoxification or long-term maintenance
- safe and used in pregnancy
- suboxone
- long acting oral administration with fewer withdrawal symptoms than methadone
- naloxone + buprenorphine (partial opioid agonist)
- naloxone is not active when taken orally, so withdrawal symptoms occur only if injected
- intended to prevent overdose / enjoyment when suboxone is injected
- Barbiturates
- intoxication
- respiratory/CNS depression
- does not have a depression "ceiling"
- treatment of intoxication
- must treat withdrawal with barbiturates, not benzodiazepines
- symptom management
- withdrawal
- anxiety, seizures, and delirium
- life-threatening cardiovascular collapse
- additive affects with alcohol
- Benzodiazepines
- intoxication
- amnesia, ataxia, stupor/somnolence, and minor respiratory depression
- has a depression "ceiling"
- additive affects with alcohol
- treat with flumazenil (competitive GABA antagonist)
- treatment for intoxication
- flumazenil (competitive GABA antagonist)
- withdrawal
- rebound anxiety
- seizures (life-threatening), tremor
- insomnia
- treatment for withdrawal
- long acting benzodiazepine (e.g., diazepam) to taper off dose
- symptomatic treatment
Stimulants
- Amphetamines
- mechanism
- simulates biogenic amine (DA, NE, and 5HT) release
- intoxication
- mental status changes
- euphoria, impaired judgment, delusions, hallucinations, and prolonged wakefulness/attention
- sympathetic activation,
- psychomotor agitation, pupillary dilation, hypertension, tachycardia, fever, and cardiac arrhythmias
- withdrawal
- depression, lethargy, headache, stomach cramps, hunger, and hypersomnolence
- MDMA ("ecstacy")
- mechanism
- similar to amphetamines
- effects 5-HT more than dopamine
- may damage serotonergic neurons
- intoxication
- hyperthermia and social closeness
- withdrawal
- Cocaine
- Caffeine
- Nicotine
Hallucinogens
- PCP
- LSD
- Marijuana; Tetrahydrocannabinol (cannabis)